ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Total Committed Value of Federal Contracts

$37.7M

Total Contracts

Total Actions

Location

New York, NY

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 19, 2021	$1,839,820
BAA, THE IMPACT OF SARS-COV-2 INFECTION DURING PREGNANCY ON OBSTETRIC AND NEONATAL OUTCOMES	Other Basic Research R&D	Centers for Disease Control and Prevention	May 19, 2021	$1,748,619
MSSM CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE.	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	March 29, 2021	$6,001,311
CYTOF AND O-LINK ASSESSMENT IN THE `NCI COVID-19 IN CANCER PATIENTS STUDY' (NCCAPS)	Medical/Health Special Studies/Analysis	National Institutes of Health	December 23, 2020	$2,712,342
THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND DISTRIBUTE CNS AND RELATED BIOLOGICAL SPECIMENS TO QUALIFIED INVESTIGATORS.	Biomedical R&D	National Institutes of Health	September 25, 2020	$0
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	August 27, 2020	$1,084,986
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 28, 2020	$738,172
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 09, 2020	$6,408,099
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 26, 2020	$423,750
THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND DISTRIBUTE CNS AND RELATED BIOLOGICAL SPECIMENS TO QUALIFIED INVESTIGATORS.	Biomedical R&D	National Institutes of Health	June 03, 2020	$81,110
BAA, THE IMPACT OF SARS-COV-2 INFECTION DURING PREGNANCY ON OBSTETRIC AND NEONATAL OUTCOMES	Other Basic Research R&D	Centers for Disease Control and Prevention	May 29, 2020	$1,813,975
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 22, 2020	$2,282,925
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 04, 2020	$1,184,771
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 21, 2020	$423,750
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 21, 2020	$3,051,550
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	March 23, 2020	$7,948,790

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.